NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹134 Cr | ₹95 Cr | ₹21 Cr | ₹285 Cr | ₹239 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹134 Cr |
Mar2022 | ₹95 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹285 Cr |
Mar2019 | ₹239 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹134 Cr | 40.68 | |
Mar2022 | ₹95 Cr | 344.38 | |
Mar2021 | ₹21 Cr | -92.50 | |
Mar2020 | ₹285 Cr | 19.11 | |
Mar2019 | ₹239 Cr | - |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹785.9 Cr | 2.6% | 16.4% | 94% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | 2.6% |
16.4% |
94% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses